Lactobacillus reuteri 17938

Investigated by: Asociacion Benefica Prisma · Johns Hopkins Bloomberg School of Public Health · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Tulane University School of Medicine · University of Virginia

today NCT02460575 · Ph 1

20192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT02460575	Jan → Dec 2019	—	Tulane University School of Medicine	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Lactobacillus reuteri 17938	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02460575 ↗
Modality	Other / unclassified	“probiotic” NCT02460575 ↗